Cavers A, Kugler M, Ozguler Y, Al Obeidi A, Hatemi G, Ueberheide B, et al. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity. Ann Rheum Dis. 2022;81:1603-1611 pubmed publisher

Zhou Z, Zhao Y, Chen S, Cui G, Fu W, Li S, et al. Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils. Front Pharmacol. 2022;13:870178 pubmed publisher

Pathania A, Prathipati P, Olwenyi O, Chava S, Smith O, Gupta S, et al. miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. Mol Ther Oncolytics. 2022;25:308-329 pubmed publisher

Zeng W, Fu L, Xu H. MicroRNA-206 relieves irradiation-induced neuroinflammation by regulating connexin 43. Exp Ther Med. 2021;22:1186 pubmed publisher

Schiferle E, Cheon S, Ham S, Son H, Messerschmidt J, Lawrence D, et al. Rejection of benign melanocytic nevi by nevus-resident CD4+ T cells. Sci Adv. 2021;7: pubmed publisher

Zeng Y, Chen X. 90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro. Aging (Albany NY). 2021;13:8355-8368 pubmed publisher

Park J, Thi E, Carpio V, Bi Y, Cole A, Dorsey B, et al. Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1. Nat Commun. 2021;12:1222 pubmed publisher

Liu T, Tan J, Wu M, Fan W, Wei J, Zhu B, et al. High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells. Gut. 2021;70:1965-1977 pubmed publisher

Do P, Perdue L, Chyong A, Hunter R, Dougan J, HENRY C, et al. Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia. ACS Comb Sci. 2020;22:533-541 pubmed publisher

Damodharan S, Walker K, Forsberg M, McDowell K, Bouchlaka M, Drier D, et al. Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation. Cytotherapy. 2020;22:450-457 pubmed publisher

Guo J, Muse E, Christians A, Swanson S, Davila E. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based Cancer Vaccine. Cancer Immunol Res. 2019;7:1523-1534 pubmed publisher

Weist M, Starr R, Aguilar B, Chea J, Miles J, Poku E, et al. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine. J Nucl Med. 2018;59:1531-1537 pubmed publisher

Brown C, Aguilar B, Starr R, Yang X, Chang W, Weng L, et al. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Mol Ther. 2018;26:31-44 pubmed publisher

Henault J, Riggs J, Karnell J, Liarski V, Li J, Shirinian L, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. 2016;17:196-203 pubmed publisher

Johnston L, La Flamme A, Larsen P, Harding S. Prasugrel inhibits platelet-enhanced pro-inflammatory CD4+ T cell responses in humans. Atherosclerosis. 2015;239:283-6 pubmed publisher

Saito T, Abe D, Nogata Y. Polymethoxylated flavones potentiate the cytolytic activity of NK leukemia cell line KHYG-1 via enhanced expression of granzyme B. Biochem Biophys Res Commun. 2015;456:799-803 pubmed publisher